1887

Abstract

Accessibility to folded RNA and low potential of variation in the target RNA are crucial requirements for ribozyme therapy against virus infections. In hepatitis C virus (HCV), the sequence of the 5′UTR is conserved but the highly folded RNA structure severely limits the number of accessible sites. To expand investigation of targeting in the HCV genome, we have considered an internal genomic region whose sequence variation has been widely investigated and which has a particularly conserved RNA structure, which makes it accessible to the human RNase P . We have first mapped the accessibility of the genomic RNA to complementary DNAs within this internal genomic region. We performed a kinetic and thermodynamic study. Accordingly, we have designed and assayed four RNase P M1 RNA guide sequence ribozymes targeted to the selected sites. Considerations of RNA structural accessibility and sequence variation indicate that several target sites should be defined for simultaneous attack.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.18898-0
2003-06-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/84/6/vir841545.html?itemId=/content/journal/jgv/10.1099/vir.0.18898-0&mimeType=html&fmt=ahah

References

  1. Cabana M., Clotet B., Martinez M. A. 1999; Emergence and genetic evolution of HIV-1 variants with mutations conferring resistance to multiple reverse transcriptase and protease inhibitors. J Med Virol 59:480–490
    [Google Scholar]
  2. Cabot B., Martell M., Esteban J. I., Sauleda S., Otero T., Esteban R., Guardia J., Gómez J. 2000; Nucleotide and amino acid complexity of hepatitis C virus quasispecies in serum and liver. J Virol 74:805–811
    [Google Scholar]
  3. Domingo E., Escarmís C., Menendez-Arias L., Holland J. J. 1999 Origin and Evolution of Viruses pp  141–161 Edited by Domingo E., Webster R. H. J. London: Academic Press;
    [Google Scholar]
  4. Guerrier-Takada C., Gardiner K., Marsh T., Pace N., Altman S. 1983; The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme. Cell 35:849–857
    [Google Scholar]
  5. Lima W. F., Brown-Driver V., Fox M., Hanecak R., Bruice T. W. 1997; Combinatorial screening and rational optimization for hybridization to folded hepatitis C virus RNA of oligonucleotides with biological antisense activity. J Biol Chem 272:626–638
    [Google Scholar]
  6. Liu F., Altman S. 1995; Inhibition of viral gene expression by the catalytic RNA subunit of RNase P from Escherichia coli . Genes Dev 9:471–480
    [Google Scholar]
  7. Lyons A. J., Lytle J. R., Gómez J., Robertson H. D. 2001; Hepatitis C virus internal ribosome entry site RNA contains a tertiary structural element in a functional domain of stem–loop II. Nucleic Acids Res 29:2535–2541
    [Google Scholar]
  8. Macejack D. G., Jensen K. L., Jamison S. F. 9 other authors 2000; Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes. Hepatology 31:769–776
    [Google Scholar]
  9. Martell M., Esteban J. I., Quer J., Genesca J., Weiner A., Esteban R., Guardia J., Gómez J. 1992; Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 66:3225–3229
    [Google Scholar]
  10. Nadal A., Martell M., Lytle J. R. 7 other authors 2002; Specific cleavage of hepatitis C virus RNA genome by human RNase P. J Biol Chem 277:30606–30613
    [Google Scholar]
  11. Trang P., Kilani A., Kim J., Liu F. 2000a; A ribozyme derived from the catalytic subunit of RNase P from Escherichia coli is highly effective in inhibiting replication of herpes simplex virus 1. J Mol Biol 301:817–826
    [Google Scholar]
  12. Trang P., Lee M., Nepomuceno E., Kim J., Zhu H., Liu F. 2000b; Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli . Proc Natl Acad Sci U S A 97:5812–5817
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.18898-0
Loading
/content/journal/jgv/10.1099/vir.0.18898-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error